|
CBWD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76999999990102E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.790600E-04 |
| Normal-vs-Stage2 |
4.627400E-04 |
| Normal-vs-Stage3 |
5.12980002920216E-09 |
| Normal-vs-Stage4 |
3.27579996461935E-09 |
| Stage1-vs-Stage2 |
4.367200E-01 |
| Stage1-vs-Stage3 |
2.239800E-03 |
| Stage1-vs-Stage4 |
2.878500E-03 |
| Stage2-vs-Stage3 |
1.631190E-01 |
| Stage2-vs-Stage4 |
1.149810E-01 |
| Stage3-vs-Stage4 |
7.866200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.25909999596041E-08 |
| Normal-vs-AfricanAmerican |
1.059240E-01 |
| Normal-vs-Asian |
3.696300E-02 |
| Caucasian-vs-AfricanAmerican |
6.158400E-03 |
| Caucasian-vs-Asian |
9.925200E-01 |
| AfricanAmerican-vs-Asian |
3.513600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75499947907554E-10 |
| Normal-vs-Female |
2.043000E-03 |
| Male-vs-Female |
1.594310E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.07319999995437E-06 |
| Normal-vs-Age(41-60Yrs) |
5.77999999973322E-07 |
| Normal-vs-Age(61-80Yrs) |
2.43980000003141E-06 |
| Normal-vs-Age(81-100Yrs) |
2.035800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.471750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.590650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.769390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.207600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.478800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.951200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.890800E-01 |
| Normal-vs-Grade 2 |
1.413670E-04 |
| Normal-vs-Grade 3 |
4.94499999947884E-07 |
| Normal-vs-Grade 4 |
7.1812555901829E-12 |
| Grade 1-vs-Grade 2 |
1.420960E-01 |
| Grade 1-vs-Grade 3 |
4.155700E-02 |
| Grade 1-vs-Grade 4 |
3.383500E-04 |
| Grade 2-vs-Grade 3 |
5.612300E-02 |
| Grade 2-vs-Grade 4 |
3.79490000002036E-06 |
| Grade 3-vs-Grade 4 |
3.537300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.290100E-02 |
| Normal-vs-ccB subtype |
1.70075065142328E-12 |
| ccA subtype-vs-ccB subtype |
3.70190544884963E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61219999994522E-06 |
| Normal-vs-N1 |
9.21339999959692E-07 |
| N0-vs-N1 |
1.929830E-02 |
|
|
